Sprycel
Brand for: Dasatinib
My Prescription
Payment
Select pharmacy
$739.70
$30.00 due at pharmacy
$739.70 - $30.00 = $709.70
$709.70 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$739.70
Print or send this coupon to your phone
AlbertsonsPowered byAbout Sprycel
Drug Details
Sprycel (dasatinib) is an oral medication prescribed for the treatment of certain cancers, specifically chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), both of which are Philadelphia chromosome-positive (Ph+). This medication functions as a targeted therapy by acting as a tyrosine kinase inhibitor. It works by blocking the BCR-ABL tyrosine kinase protein found on cancer cells, which is responsible for their growth and multiplication. By inhibiting this protein, Sprycel effectively kills cancer cells and prevents their spread. It is typically taken once daily, offering a convenient treatment option for adults. Patients should be aware that common side effects may include diarrhea, fluid retention, or swelling. As always, it's important to consult with healthcare professionals to ensure this treatment is appropriate for your condition.
Sprycel (Dasatinib) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 20MG | 60 Tablets | $375.00 | $6.25 |
| 50MG | 60 Tablets | $784.20 | $13.07 |
| 70MG | 60 Tablets | $649.80 | $10.83 |
| 80MG | 30 Tablets | $625.80 | $20.86 |
| 100MG | 30 Tablets | $739.70 | $24.66 |
| 140MG | 30 Tablets | $649.20 | $21.64 |
Sprycel FAQs
Yes, Sprycel (dasatinib) is considered a type of chemotherapy. It is a targeted therapy used to treat certain types of leukemia by inhibiting specific proteins that promote cancer cell growth.
Sprycel is used to treat certain types of leukemia, specifically chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive.
The high cost of Sprycel can be attributed to several factors, including the research and development expenses involved in creating the drug, the costs associated with clinical trials, and the regulatory approval process. Additionally, Sprycel is a targeted therapy for specific types of cancer, which often involves complex manufacturing processes. Market exclusivity and patent protection can also contribute to its high price, as they limit competition from generic alternatives.
The main side effects of dasatinib can include myelosuppression (such as low blood cell counts), fluid retention, diarrhea, headache, fatigue, nausea, and skin rash. It is important for patients to discuss any side effects they experience with their healthcare provider, as they may require management or adjustment of the treatment.
The cost of SPRYCEL (dasatinib) without insurance can vary significantly depending on the pharmacy and location. On average, the price for a 30-day supply of 100 mg tablets can range from $10,000 to $15,000. It's advisable to check with local pharmacies for specific pricing and explore patient assistance programs that may help reduce the cost.